Bausch + Lomb Corporation

NYSE (USD): Bausch + Lomb Corporation (BLCO)

Last Price

20.71

Today's Change

-0.16 (0.76%)

Day's Change

20.64 - 21.34

Trading Volume

758,520

Overview

Market Cap

7 Billion

Shares Outstanding

351 Million

Avg Volume

804,979

Avg Price (50 Days)

17.28

Avg Price (200 Days)

15.88

PE Ratio

-16.08

EPS

-1.29

Earnings Announcement

30-Oct-2024

Previous Close

20.87

Open

21.33

Day's Range

20.64 - 21.34

Year Range

13.16 - 21.69

Trading Volume

765,556

Price Change Highlight

1 Day Change

-0.62%

5 Day Change

10.32%

1 Month Change

33.38%

3 Month Change

30.93%

6 Month Change

45.03%

Ytd Change

22.58%

1 Year Change

23.31%

3 Year Change

3.70%

5 Year Change

3.70%

10 Year Change

3.70%

Max Change

3.70%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Instruments & Supplies

Description:

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment